Mechanical cervicAl ripeninG for Women with PrOlongedPregnancies (MAGPOP): Protocol for a Randomised Controlled Trial of a Silicone Double Balloon Catheter versus the Propess System for the Slow Release of Dinoprostone for Cervical Ripening of Prolonged Pregnancies
Résumé
INTRODUCTION: Induction of labour for prolonged pregnancies (PP) when the cervix is unfavourable is a challenging situation. Cervical ripening by pharmacological or mechanical techniques before oxytocin administration is used to increase the likelihood of vaginal delivery. Both techniques are equally effective in achieving vaginal delivery but excessive uterine activity, which induces fetal heart rate (FHR) anomalies, is more frequent after the pharmacological intervention. We hypothesised that mechanical cervical ripening could reduce the caesarean rate for non-reassuring FHR especially in PP where fetuses are already susceptible to this. METHODS AND ANALYSIS: A multicentre, superiority, open-label, parallel-group, randomised controlled trial that aims to compare cervical ripening with a mechanical device (Cervical Ripening Balloon, Cook-Medical Europe, Ireland) inserted in standardised manner for 24\,hours to pharmacological cervical ripening (Propess system for slow release system of 10\,mg of dinoprostone, Ferring SAS, France) before oxytocin administration. Women (n=1220) will be randomised in a 1:1 ratio in 15 French units. Participants will be women with a singleton pregnancy, a vertex presentation, a term ≥q41+0\,and≤q42+0\,week's gestation, and for whom induction of labour is planned. Women with a Bishop score ≥q6, a prior caesarean delivery, premature rupture of membranes or with any contraindication for vaginal delivery will be excluded. The primary endpoint is the caesarean rate for non-reassuring FHR. Secondary outcomes are related to delivery and perinatal morbidity. As study investigators and patients cannot be masked to treatment assignment, to compensate for the absence of blinding, an independent endpoint adjudication committee, blinded to group allocation, will determine whether the caesarean for non-reassuring FHR was justified. ETHICS AND DISSEMINATION: Written informed consent will be obtained from all participants. The Tours Research ethics committee has approved this study (2016-R23, 29 November 2016). Study findings will be submitted for publication and presented at relevant conferences. TRIAL REGISTRATION NUMBER: NCT02907060; pre-results.
Mots clés
Adolescent
Adult
Catheters
Cervical Ripening
Cervix Uteri
cesarean
Delayed-Action Preparations
Delivery
Obstetric
Dinoprostone
Female
France
Heart Rate
Fetal
Humans
Ireland
Labor
Induced
mechanical cervical ripening
Oxytocics
Oxytocin
Pregnancy
Prolonged pregnancy
Research Design
Silicones
Young Adult